Invega Sustenna Alternatives Compared
Invega Sustenna | Seroquel | Abilify |
|
---|
Invega Sustenna (paliperidone) | Seroquel (quetiapine) | Abilify (aripiprazole) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Invega Sustenna is a long-acting form of paliperidone that is injected into the deltoid or gluteal muscle once a month after an initial loading dose. It is similar in its pharmacology and action to... View more |
Prescription only
Seroquel is an antipsychotic that helps to calm and relieve psychotic thoughts. It is often given because it is quite sedating; however, care is needed because it also lowers blood pressure... View more |
Prescription only
Abilify is an antipsychotic used in the treatment of schizophrenia and several other disorders. Abilify is less likely than some other antipsychotics to cause weight gain. Prescribed for Bipolar... View more |
Related suggestions Schizophrenia
Schizoaffective Disorder
Popular comparisons
|
|||||||||||||||||||||||
More about Invega Sustenna (paliperidone) | More about Seroquel (quetiapine) | More about Abilify (aripiprazole) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Invega Sustenna has an average rating of 3.8 out of 10 from a total of 191 ratings on Drugs.com. 25% of reviewers reported a positive effect, while 62% reported a negative effect. |
Seroquel has an average rating of 7.0 out of 10 from a total of 676 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 21% reported a negative effect. |
Abilify has an average rating of 6.0 out of 10 from a total of 1172 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 34% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Invega Sustenna side effects in more detail. |
See also: Seroquel side effects in more detail. |
See also: Abilify side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Invega Sustenna prices |
View all Seroquel prices |
View all Abilify prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other paliperidone brands include: Invega, Invega Hafyera, Invega Trinza | Other quetiapine brands include: Seroquel XR | Other aripiprazole brands include: Abilify Asimtufii, Abilify Maintena, Abilify MyCite, Aristada, Aristada Initio | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
23 hours |
6 hours |
146 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 619 drugs are known to interact with Invega Sustenna:
|
A total of 708 drugs are known to interact with Seroquel:
|
A total of 713 drugs are known to interact with Abilify:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
July 31, 2009 |
September 26, 1997 |
November 15, 2002 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.